Header cover image

South African (JSE) Pharma Industry Analysis

UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies4
  • 7D3.8%
  • 3M-1.5%
  • 1Y-4.6%
  • YTD5.5%

In the last week, the Pharma industry is up 5.5%, with all of the companies up. However, the industry is down 4.5% over the past year. As for the next few years, earnings are expected to grow by 22% per annum.

Industry Valuation and Performance

Has the South African Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 01 Feb 2025R89.9bR55.8bR5.3b15.3x17.1x1.6x
Mon, 30 Dec 2024R86.3bR55.8bR5.3b15.1x16.4x1.5x
Wed, 27 Nov 2024R85.3bR55.8bR5.3b14.6x16.2x1.5x
Fri, 25 Oct 2024R90.5bR55.8bR5.3b15.1x17.2x1.6x
Sun, 22 Sep 2024R95.1bR55.8bR5.3b15.7x18.1x1.7x
Tue, 20 Aug 2024R112.6bR53.4bR5.7b21.3x19.8x2.1x
Thu, 18 Jul 2024R111.9bR53.4bR5.7b21x19.7x2.1x
Sat, 15 Jun 2024R107.0bR53.4bR5.7b14.9x18.8x2x
Mon, 13 May 2024R111.2bR53.4bR5.7b15.3x19.5x2.1x
Wed, 10 Apr 2024R106.5bR53.4bR5.7b14.7x18.7x2x
Fri, 08 Mar 2024R97.8bR53.4bR5.5b13.9x17.9x1.8x
Sun, 04 Feb 2024R94.5bR51.4bR5.8b13x16.2x1.8x
Tue, 02 Jan 2024R100.2bR51.4bR5.8b13.8x17.2x2x
Thu, 30 Nov 2023R89.8bR51.4bR5.8b12.3x15.4x1.7x
Sat, 28 Oct 2023R82.9bR51.4bR5.8b11.6x14.2x1.6x
Mon, 25 Sep 2023R85.8bR51.4bR5.9b12.1x14.6x1.7x
Wed, 23 Aug 2023R92.1bR49.0bR6.4b11.9x14.4x1.9x
Fri, 21 Jul 2023R92.4bR49.0bR6.4b11.9x14.4x1.9x
Sun, 18 Jun 2023R92.7bR49.0bR6.4b12x14.5x1.9x
Tue, 16 May 2023R85.8bR49.0bR6.4b11.3x13.4x1.8x
Thu, 13 Apr 2023R91.1bR49.0bR6.4b11.7x14.2x1.9x
Sat, 11 Mar 2023R92.0bR49.0bR5.9b12x15.5x1.9x
Mon, 06 Feb 2023R75.3bR48.9bR6.5b10.4x11.5x1.5x
Wed, 04 Jan 2023R69.2bR48.9bR6.5b9.7x10.6x1.4x
Fri, 02 Dec 2022R72.0bR48.9bR6.5b9.7x11x1.5x
Sun, 30 Oct 2022R75.8bR48.9bR6.5b10x11.6x1.6x
Tue, 27 Sep 2022R68.1bR49.3bR5.8b9.3x11.7x1.4x
Thu, 25 Aug 2022R71.0bR48.9bR5.2b10.6x13.7x1.5x
Sat, 23 Jul 2022R75.8bR48.9bR5.2b11x14.7x1.5x
Mon, 20 Jun 2022R70.0bR48.9bR5.2b10.7x13.6x1.4x
Wed, 18 May 2022R79.9bR48.9bR5.2b11.7x15.5x1.6x
Fri, 15 Apr 2022R90.4bR48.9bR5.2b12.7x17.5x1.8x
Sun, 13 Mar 2022R86.5bR48.3bR5.1b13.1x17x1.8x
Tue, 08 Feb 2022R100.5bR45.5bR5.5b15.8x18.4x2.2x
Price to Earnings Ratio

18.4x


Total Market Cap: R100.5bTotal Earnings: R5.5bTotal Revenue: R45.5bTotal Market Cap vs Earnings and Revenue0%0%0%
South African Pharma Industry Price to Earnings3Y Average 15.7x202320242025
Current Industry PE
  • Investors are relatively neutral on the South African Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 15.7x.
  • The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 7.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the South African Healthcare industry?

ZA Market1.79%
Healthcare2.01%
Pharma3.78%
Pharma3.78%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
APN Aspen Pharmacare HoldingsR178.504.2%
+R3.2b
-6.8%PE18x
ASC Ascendis HealthR0.847.7%
+R37.5m
5.0%PE12.6x
CCC Cilo Cybin HoldingsR4.3213.7%
+R36.9m
n/aPE253.2x
AIP Adcock Ingram HoldingsR66.840.4%
+R35.2m
16.7%PE12.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

APN

R178.50

Aspen Pharmacare Holdings

7D

4.2%

1Y

-6.8%

CCC

R4.32

Cilo Cybin Holdings

7D

13.7%

1Y

n/a

ASC

R0.84

Ascendis Health

7D

7.7%

1Y

5.0%